| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Karyopharm Therapeutics Inc. (KPTI) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. KPTI is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 198.3K | $1.79M | - | |
| VP | 79.5K | $717.1K | - | |
| VP | 67.4K | $607.9K | - | |
| VP | 65.1K | $587.0K | - | |
| VP | 56.3K | $507.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 3, 2025 | Abate Kristin | Chief Accounting Officer | Sell | 12 | $6.78 | $81.36 | -0.1% | -24.3% | - | |
| Jul 29, 2025 | Poulton Stuart78 | EVP, Chief Development Officer | Sell | 191 | $4.37 | $834.67 | -0.7% | +55.4% | - | |
| Jul 22, 2025 | Abate Kristin | Chief Accounting Officer | Sell | 238 | $4.00 | $952.00 | -2.5% | +66.3% | - | |
| May 6, 2025 | Paulson Richard A.79 | President And CEO | Sell | 236 | $7.12 | $1,680.32 | -0.3% | -35.9% | +43.9% | |
| Apr 23, 2025 | Rangwala Reshma67 | EVP &Chief Medical Officer | Sell | 419 | $6.17 | $2,585.23 | -1.4% | -38.0% | +39.6% | |
| Apr 4, 2025 | Paulson Richard A.79 | President And CEO | Sell | 245 | $3.74 | $916.30 | -0.3% | +13.7% | +63.7% | |
| Mar 4, 2025 | Rangwala Reshma67 | EVP &Chief Medical Officer | Sell | 3,587 | $6.29 | $22,562.23 | -10.9% | -35.3% | +43.1% | |
| Mar 4, 2025 | Paulson Richard A.79 | President And CEO | Sell | 11,694 | $6.29 | $73,555.26 | -12.4% | -35.3% | +43.1% | |
| Mar 4, 2025 | Mano Michael69 | SVP, General Counsel&Secretary | Sell | 2,793 | $6.29 | $17,567.97 | -11.7% | -35.3% | +43.1% | |
| Mar 4, 2025 | Poulton Stuart78 | EVP, Chief Development Officer | Sell | 3,548 | $6.29 | $22,316.92 | -11.5% | -35.3% | +43.1% |